Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

254 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunogenic cell death in cancer therapy.
Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Kroemer G, et al. Among authors: kepp o. Annu Rev Immunol. 2013;31:51-72. doi: 10.1146/annurev-immunol-032712-100008. Epub 2012 Nov 12. Annu Rev Immunol. 2013. PMID: 23157435 Review.
Molecular characteristics of immunogenic cancer cell death.
Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Tesniere A, et al. Among authors: kepp o. Cell Death Differ. 2008 Jan;15(1):3-12. doi: 10.1038/sj.cdd.4402269. Epub 2007 Nov 16. Cell Death Differ. 2008. PMID: 18007663 Review.
Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin.
Tufi R, Panaretakis T, Bianchi K, Criollo A, Fazi B, Di Sano F, Tesniere A, Kepp O, Paterlini-Brechot P, Zitvogel L, Piacentini M, Szabadkai G, Kroemer G. Tufi R, et al. Among authors: kepp o. Cell Death Differ. 2008 Feb;15(2):274-82. doi: 10.1038/sj.cdd.4402275. Epub 2007 Nov 23. Cell Death Differ. 2008. PMID: 18034188
Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death.
Tajeddine N, Galluzzi L, Kepp O, Hangen E, Morselli E, Senovilla L, Araujo N, Pinna G, Larochette N, Zamzami N, Modjtahedi N, Harel-Bellan A, Kroemer G. Tajeddine N, et al. Among authors: kepp o. Oncogene. 2008 Jul 10;27(30):4221-32. doi: 10.1038/onc.2008.63. Epub 2008 Mar 24. Oncogene. 2008. PMID: 18362892
Disruption of the hexokinase-VDAC complex for tumor therapy.
Galluzzi L, Kepp O, Tajeddine N, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Oncogene. 2008 Aug 7;27(34):4633-5. doi: 10.1038/onc.2008.114. Epub 2008 May 12. Oncogene. 2008. PMID: 18469866
Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G. Tesniere A, et al. Among authors: kepp o. Curr Opin Immunol. 2008 Oct;20(5):504-11. doi: 10.1016/j.coi.2008.05.007. Epub 2008 Jun 23. Curr Opin Immunol. 2008. PMID: 18573340 Review.
Targeting p53 to mitochondria for cancer therapy.
Galluzzi L, Morselli E, Kepp O, Tajeddine N, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Cell Cycle. 2008 Jul 1;7(13):1949-55. doi: 10.4161/cc.7.13.6222. Cell Cycle. 2008. PMID: 18642442 Review.
Life, death and burial: multifaceted impact of autophagy.
Galluzzi L, Morselli E, Vicencio JM, Kepp O, Joza N, Tajeddine N, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Biochem Soc Trans. 2008 Oct;36(Pt 5):786-90. doi: 10.1042/BST0360786. Biochem Soc Trans. 2008. PMID: 18793137 Review.
Targeting post-mitochondrial effectors of apoptosis for neuroprotection.
Galluzzi L, Morselli E, Kepp O, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Biochim Biophys Acta. 2009 May;1787(5):402-13. doi: 10.1016/j.bbabio.2008.09.006. Epub 2008 Sep 24. Biochim Biophys Acta. 2009. PMID: 18848916 Review.
The immunogenicity of tumor cell death.
Kepp O, Tesniere A, Zitvogel L, Kroemer G. Kepp O, et al. Curr Opin Oncol. 2009 Jan;21(1):71-6. doi: 10.1097/CCO.0b013e32831bc375. Curr Opin Oncol. 2009. PMID: 19125021 Review.
254 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback